Aplastic Anemia Following Acetazolamide Therapy

Lubeck, Marvin J.

doi:10.1016/0002-9394(70)91640-5

Search citation statements

Order By: Relevance

Paper Sections

Select...

Carbonic Anhydrase Inhibitors1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1973

2013

Publication Types

Select...

Book3

Article2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 12 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients present with a constellation of symptoms, including fever, easily bruised skin, purpura, sore throat, paleness, nosebleeds, petechaie, and perhaps jaundice. 298,299 The use of blood tests to monitor for blood dyscrasias is controversial. 300 In an editorial in 2000, 301 Fraunfelder and Bagby weigh the pros and cons of doing routine, periodic blood tests on patients taking oral CAIs, hopefully to catch early any abnormalities and to be able to cease the drug and treat the reversible cases.…”

Section: Carbonic Anhydrase Inhibitorsmentioning

confidence: 99%

Medications Used to Treat Glaucoma

Schacknow

Samples

2010

The Glaucoma Book

View full text Add to dashboard Cite

ConclusionOptimal therapy for glaucoma would involve IOP control throughout the 24-h period. However, not all therapies are equally efficacious at all times of the day and night. Understanding of the mechanisms of action of different therapies, along with the knowledge of the circadian changes in aqueous humor dynamics, allows us to predict the therapies that will provide the most consistent IOP reduction. As well, understanding of aqueous humor dynamics may help in the development of future therapies with consistent 24-h IOP control. Bibliography

show abstract